Study Watch with Irregular Pulse Monitor (Home) vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Study Watch with Irregular Pulse Monitor (Home)

by Verily Life Sciences LLC

EchoNext

by Pathway Labs

AI Verdict

Tool A, the Verily Study Watch, is a wearable device focused on continuous physiological data collection, including irregular pulse monitoring for AFib detection, primarily for clinical research and prescription use. Tool B, EchoNext, is an AI tool that analyzes standard 12-lead ECGs to detect hidden structural heart diseases like heart failure and valve disease. While both are in cardiology AI and utilize ECG data, their primary function and deployment differ, with Verily focused on long-term monitoring and EchoNext on diagnostic support for specific structural conditions.

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if your primary goal is continuous, unobtrusive physiological data collection for clinical research or long-term remote patient monitoring. This prescription-only wearable excels at on-demand single-channel ECG measurements and irregular pulse monitoring for AFib detection, making it ideal for studies requiring extensive, real-world data capture beyond a single point in time. Its long battery life and large internal storage support prolonged data collection in a home setting.

View Study Watch with Irregular Pulse Monitor (Home) →

Choose EchoNext if…

Choose EchoNext if you need an FDA-cleared AI tool to quickly analyze standard 12-lead ECGs for the detection of hidden structural heart disease. This solution is best suited for clinical settings where rapid, non-invasive screening for conditions like heart failure, valve disease, and pulmonary hypertension is crucial. EchoNext provides valuable diagnostic support by leveraging existing ECG infrastructure, making it an efficient addition to a broad range of practices from major hospitals to community settings.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Study Watch with Irregular Pulse Monitor (Home)	EchoNext
Pricing	Contact for pricing	Starts at $600/month
Deployment	Wearable device with cloud-based data processing.	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Study Watch with Irregular Pulse Monitor (Home)

Tool A, the Verily Study Watch, is a wearable device designed for unobtrusive data collection, making it highly user-friendly for patients in a home setting. Tool B, EchoNext, requires integration with the OpenEvidence platform and analysis of standard ECGs, which, while valuable, may involve more steps for healthcare providers than the passive data collection of a wearable.

Clinical Value

Tie

Both tools offer significant clinical value in cardiology. Tool A provides continuous physiological data and irregular pulse monitoring for AFib detection, which is crucial for proactive management. Tool B analyzes standard ECGs to detect hidden structural heart disease, offering a non-invasive diagnostic aid for several serious conditions. Their value propositions are distinct but equally impactful in different clinical scenarios.

Pricing & Value

EchoNext

Tool B, EchoNext, has transparent tiered pricing starting at $600/month, with discounts and add-ons clearly outlined. Tool A, the Verily Study Watch, requires contacting for pricing, and its details state it's not for direct consumer sale, making its value proposition less clear for general clinical adoption outside of research.

Enterprise Readiness

EchoNext

Tool B, EchoNext, is designed for broad access, from major hospitals to community practices, and is available through the OpenEvidence clinical decision support platform, indicating a clear strategy for enterprise deployment and integration. Tool A, while powerful, is primarily positioned for clinical research and prescription use, which may limit its immediate enterprise-wide readiness for general clinical workflows.

Innovation

Tie

Both tools demonstrate significant innovation. Tool A utilizes advanced physiological and environmental sensors in a wearable for continuous, unobtrusive data collection and cloud-based analytics. Tool B employs AI to analyze standard ECGs for the detection of hidden structural heart disease, transforming a common diagnostic test into a powerful screening tool. Both represent cutting-edge applications of AI in healthcare.

Support & Docs

Tie

Based on the provided information, neither tool explicitly details their support or documentation offerings. Without further information, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Study Watch with Irregular Pulse Monitor (Home)	EchoNext
Name	Study Watch with Irregular Pulse Monitor (Home)	EchoNext
Company	Verily Life Sciences LLC	Pathway Labs
Primary Function	On-demand single-channel ECG measurement, Irregular pulse monitoring for atrial fibrillation (AFib) detection	AI-powered ECG analysis for detection of hidden structural heart disease (heart failure, valve disease, pulmonary hypertension)
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics

Videos

Demos, reviews, and walkthroughs featuring Study Watch with Irregular Pulse Monitor (Home) and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into existing clinical workflows for a physician?

The Verily Study Watch is a prescription-only wearable designed for continuous, unobtrusive physiological data collection, including ECG and irregular pulse monitoring, with data processed in the cloud. EchoNext, on the other hand, integrates with the OpenEvidence clinical decision support platform, aiming to embed its ECG analysis directly into common clinical workflows that many physicians already use during patient visits, rather than requiring a separate system.

What is the depth of EHR integration for each tool?

The Verily Study Watch is used in research to collect and organize various health data, including ECG and traditional clinical data like EHRs, with the goal of integrating mobile health data into clinical care. Verily's Pre platform, which the Study Watch can leverage, is designed for AI-powered data readiness for research and care, curating and unifying multi-source health data into a clinically informed data model. EchoNext's integration with OpenEvidence allows its screening output to be placed directly within a platform used by many physicians, suggesting a streamlined approach to incorporating its findings into existing EHR-related workflows.

What are the accuracy and sensitivity of each tool for its respective indications?

The Verily Study Watch has demonstrated high accuracy in identifying atrial fibrillation, with a sensitivity of 96.1% and specificity of 98.1% for interval-level AF detection in a multicenter study. EchoNext has shown high diagnostic accuracy in detecting hidden structural heart disease from standard ECGs, outperforming cardiologists with 77% accuracy compared to 64% for cardiologists, and achieving an AUROC of 85% in internal tests and 78-80% in external validation.

What is the learning curve for physicians to effectively use each tool?

The Verily Study Watch is described as easy for physicians to explain to patients, leading to high usage in studies. EchoNext, by integrating with the widely used OpenEvidence platform, aims to make its breakthrough in heart disease detection available within tools physicians already use, which could suggest a reduced learning curve as it leverages familiar interfaces.

What clinical context helps a physician choose between these two tools?

The Verily Study Watch is a prescription-only wearable focused on continuous irregular pulse monitoring for AFib detection and on-demand single-channel ECG measurements, suitable for long-term monitoring and clinical research. EchoNext is an AI tool that analyzes standard 12-lead ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, serving as a screening tool to identify patients who should be referred for an echocardiogram.

Are there audit-trail features available for these tools?

While specific audit-trail features for the Verily Study Watch are not detailed, its design for clinical research and prescription use implies a need for robust data logging and accountability. For EchoNext, as a cloud-based AI tool, advanced security measures like role-based access control (RBAC), cloud logging, and Security Information and Event Management (SIEM) align with HIPAA's audit requirements and offer greater control and visibility.